Titan Medical Inc.
Toronto Stock ExchangeTotal Valuation
Titan Medical Inc. carries a market capitalization of 128.30M, placing it among publicly traded companies globally. Its enterprise value stands at 101.11M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 128.30M |
| Enterprise Value | 101.11M |
Share Statistics
Titan Medical Inc. currently has 114.04M shares outstanding.
| Shares Outstanding | 114.04M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Titan Medical Inc. trades at a trailing price-to-earnings ratio of 29.73. The price-to-sales ratio is 109.38, and the price-to-book ratio stands at -4.11.
| PE Ratio | 29.73 |
| PS Ratio | 109.38 |
| PB Ratio | -4.11 |
| P/TBV Ratio | 38.08 |
| P/FCF Ratio | -17.69 |
| P/OCF Ratio | -16.59 |
Enterprise Valuation
On an enterprise value basis, Titan Medical Inc. trades at an EV/EBITDA multiple of 10,911.63 and an EV/FCF ratio of 26.45. The EV/Sales ratio of 106.43 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.55 provides insight into valuation relative to core operating earnings.
| EV / Sales | 106.43 |
| EV / EBITDA | 10,911.63 |
| EV / EBIT | 13.55 |
| EV / FCF | 26.45 |
Financial Position
Titan Medical Inc. maintains a current ratio of 3.73, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.23, indicating elevated leverage, while an interest coverage ratio of -14.83 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.73 |
| Quick Ratio | 3.41 |
| Debt / Equity | 40.23 |
| Debt / EBITDA | -0.51 |
| Interest Coverage | -14.83 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -58.12 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -1.52 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | 3,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Titan Medical Inc.'s stock has gained approximately 1084.21053% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 1084.21053% |
| 50-Day Moving Average | 0.07 |
| 200-Day Moving Average | 0.07 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Titan Medical Inc. generated 950,000.00 in revenue and converted that into -5.05M in net income, yielding earnings per share of -0.04. EBITDA reached -2.16M, while operating income came in at -2.28M.
| Revenue | 950,000.00 |
| Gross Profit | N/A |
| Operating Income | -2.28M |
| Pretax Income | -5.02M |
| Net Income | -5.05M |
| EBITDA | -2.16M |
| EBIT | -2.28M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
Titan Medical Inc. holds 3.90M in cash and equivalents against 1.10M in total debt, resulting in a net debt position of -3.90M. Total book value stands at -25.26M, with working capital of 3.25M providing operational flexibility.
| Cash & Cash Equivalents | 3.90M |
| Total Debt | 1.10M |
| Net Debt | -3.90M |
| Equity (Book Value) | -25.26M |
| Book Value Per Share | -0.22 |
| Working Capital | 3.25M |
Cash Flow
Titan Medical Inc. produced -6.26M in operating cash flow over the past twelve months. After subtracting -116,000.00 in capital expenditures, free cash flow totaled -6.38M - equivalent to -0.06 per share.
| Operating Cash Flow | -6.26M |
| Capital Expenditures | -116,000.00 |
| Free Cash Flow | -6.38M |
| FCF Per Share | -0.06 |
Margins
Titan Medical Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -240.53 and net profit margin of -531.26 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -240.53 |
| Pretax Margin | -528.42 |
| Profit Margin | -531.26 |
| EBITDA Margin | -227.89 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.56 |
| FCF Yield | -5.65 |
Stock Splits
Titan Medical Inc.'s most recent stock split took place on June 19, 2018 with a 30:1 split ratio.
| Last Split Date | 6/19/2018 |
| Split Ratio | 30:1 |
Scores
Titan Medical Inc. posts an Altman Z-Score of -56.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -56.03 |